NCT04531371

Brief Summary

Emergence agitation is a postanesthetic phenomenon that develops in the early phase of general anesthesia recovery, and is characterized by agitation, confusion, disorientation, and possible violent behavior. Though agitation is observed more frequently in pediatric patients, the incidence in adults has been reported at 4.7% or 21.3%. Emergence agitation can lead to serious consequences such as self-extubation, removal of catheters, hemorrhage, and even severe injuries from falling out of the bed. Furthermore, it may increase the demand on human resources and cause medical staff injuries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jun 2020

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 28, 2020

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

August 28, 2020

Status Verified

August 1, 2020

Enrollment Period

3 months

First QC Date

August 23, 2020

Last Update Submit

August 25, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • post operative emergence agitation

    in post anesthetic recovery unit

    an hour

Study Arms (3)

dexemedetomidine

EXPERIMENTAL

dexemedetomidine was administered intravenously after induction of general anesthesia.

Drug: Dexmedetomidine injection

magnesium sulphage

ACTIVE COMPARATOR

magnesium sulphate was infused through out the surgery after induction of general anaesthesia.

Drug: Dexmedetomidine injection

saline

PLACEBO COMPARATOR

nothing was given just saline during the operation.

Drug: Dexmedetomidine injection

Interventions

post surgical agitation prophylaxis

Also known as: dexemedetomidine
dexemedetomidinemagnesium sulphagesaline

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Both genders
  • Aged 20-40 years.
  • With American Society of Anesthesiologists (ASA) physical status I or II.
  • Nonsmokers.
  • BMI less than or equal to 30.
  • Elective nasal surgery under general anesthesia in which nasal packing on each side was used postoperatively.

You may not qualify if:

  • Patients with history of uncontrolled hypertension.
  • Patients with ischemic or valvular heart disease.
  • Patients use MAO inhibitors or adrenergic block.
  • Cognitive impairment.
  • Patients taking antipsychotics.
  • Renal insufficiency or liver impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Valley University

Qina, Egypt

RECRUITING

MeSH Terms

Interventions

Dexmedetomidine

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Gad S Gad, MD

    South Valley University

    STUDY DIRECTOR

Central Study Contacts

ossama H salman, MD,PhD

CONTACT

. Ahmed akkaway, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

August 23, 2020

First Posted

August 28, 2020

Study Start

June 1, 2020

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

August 28, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will share

Locations